BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cole L, Fernandes D, Hussain MT, Kaszuba M, Stenson J, Markova N. Characterization of Recombinant Adeno-Associated Viruses (rAAVs) for Gene Therapy Using Orthogonal Techniques. Pharmaceutics 2021;13:586. [PMID: 33923984 DOI: 10.3390/pharmaceutics13040586] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Doan TNK, Le MD, Bajrovic I, Celentano L, Krause C, Balyan HG, Svancarek A, Mote A, Tretiakova A, Jude Samulski R, Croyle MA. Thermostability and in vivo performance of AAV9 in a film matrix. Commun Med 2022;2:148. [DOI: 10.1038/s43856-022-00212-6] [Reference Citation Analysis]
2 Yang T, Braun M, Lembke W, Mcblane F, Kamerud J, Dewall S, Tarcsa E, Fang X, Hofer L, Kavita U, Upreti VV, Gupta S, Loo L, Johnson AJ, Chandode RK, Stubenrauch K, Vinzing M, Xia CQ, Jawa V. Immunogenicity assessment of AAV-based gene therapies: An IQ consortium industry white paper. Molecular Therapy - Methods & Clinical Development 2022;26:471-94. [DOI: 10.1016/j.omtm.2022.07.018] [Reference Citation Analysis]
3 Kopra K, Hassan N, Vuorinen E, Valtonen S, Mahran R, Habib H, Jalkanen P, Susi P, Hytönen V, Hankaniemi M, Ylä-Herttuala S, Kakkola L, Peurla M, Härmä H. Rapid high-throughput compatible label-free virus particle quantification method based on time-resolved luminescence. Anal Bioanal Chem 2022. [PMID: 35581427 DOI: 10.1007/s00216-022-04104-5] [Reference Citation Analysis]
4 Chu L, Wickramasinghe SR, Qian X, Zydney AL. Retention and Fouling during Nanoparticle Filtration: Implications for Membrane Purification of Biotherapeutics. Membranes 2022;12:299. [DOI: 10.3390/membranes12030299] [Reference Citation Analysis]
5 Markova N, Cairns S, Jankevics-Jones H, Kaszuba M, Caputo F, Parot J. Biophysical Characterization of Viral and Lipid-Based Vectors for Vaccines and Therapeutics with Light Scattering and Calorimetric Techniques. Vaccines (Basel) 2021;10:49. [PMID: 35062710 DOI: 10.3390/vaccines10010049] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Shmidt AA, Egorova TV. PCR-Based Analytical Methods for Quantification and Quality Control of Recombinant Adeno-Associated Viral Vector Preparations. Pharmaceuticals (Basel) 2021;15:23. [PMID: 35056080 DOI: 10.3390/ph15010023] [Reference Citation Analysis]
7 Roesch A, Zölls S, Stadler D, Helbig C, Wuchner K, Kersten G, Hawe A, Jiskoot W, Menzen T. Particles in Biopharmaceutical Formulations, Part 2: An Update on Analytical Techniques and Applications for Therapeutic Proteins, Viruses, Vaccines and Cells. J Pharm Sci 2021:S0022-3549(21)00689-4. [PMID: 34919969 DOI: 10.1016/j.xphs.2021.12.011] [Reference Citation Analysis]
8 Ramsey JP, Khatwani SL, Lin M, Boregowda R, Surosky R, Andrew Ramelmeier R. Overview of analytics needed to support a robust gene therapy manufacturing process. Current Opinion in Biomedical Engineering 2021;20:100339. [DOI: 10.1016/j.cobme.2021.100339] [Reference Citation Analysis]
9 Singh SM, Furman R, Singh RK, Balakrishnan G, Chennamsetty N, Tao L, Li Z. Size exclusion chromatography for the characterization and quality control of biologics. Journal of Liquid Chromatography & Related Technologies 2021;44:265-78. [DOI: 10.1080/10826076.2021.1979582] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]